drugset / Trial / NCT02372318
Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity
Phase 0
Terminated
23 enrolled
Central Institute of Mental Health, Mannheim
Lundbeck GmbH, Ericusspitze 2, 20457 Hamburg · collab
RandomizedCrossoverTriple-blindBasic science
Summary
The aim of this study is to use functional Magnetic Resonance Imaging (fMRI) to measure neural reactivity to alcohol-related and emotional cues in alcohol dependent subjects following a single dose of the opioid receptor modulator nalmefene. The study will be done in a cross over design with nalmefene versus placebo.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalmefene | Small molecule | 18 mg | Oral |